Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.
Jürgens M, Mahachie John JM, Cleynen I, Schnitzler F, Fidder H, van Moerkercke W, Ballet V, Noman M, Hoffman I, van Assche G, Rutgeerts PJ, van Steen K, Vermeire S.
Jürgens M, et al. Among authors: ballet v.
Clin Gastroenterol Hepatol. 2011 May;9(5):421-7.e1. doi: 10.1016/j.cgh.2011.02.008. Epub 2011 Feb 17.
Clin Gastroenterol Hepatol. 2011.
PMID: 21334460